Revenue: The sum of all revenue fields included for a company's operating activities.
Niagen Bioscience, Inc. (NAGE) had Revenue of $33.99M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
|
Revenue |
$33.99M |
$4.58M |
|
$12.06M |
|
$21.93M |
|
$29.75M |
|
$4.24M |
|
$0.56M |
|
$4.80M |
|
$4.80M |
|
$4.58M |
|
$4.58M |
|
$4.58M |
|
$4.58M |
|
$4.24M |
|
$4.43M |
|
79.78M |
|
86.62M |
|
$0.06 |
|
$0.05 |
|
| Balance Sheet Financials | |
$93.62M |
|
$1.50M |
|
$4.52M |
|
$98.14M |
|
$22.71M |
|
-- |
|
$4.75M |
|
$27.46M |
|
$70.68M |
|
$70.43M |
|
$70.68M |
|
79.64M |
|
| Cash Flow Statement Financials | |
$12.82M |
|
$-0.19M |
|
$7.00M |
|
$44.66M |
|
$64.29M |
|
$19.63M |
|
$4.32M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.12 |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
64.52% |
|
12.46% |
|
12.46% |
|
-- |
|
14.12% |
|
13.47% |
|
$12.63M |
|
-- |
|
-- |
|
-- |
|
0.35 |
|
0.64 |
|
4.00 |
|
22.53 |
|
6.48% |
|
6.50% |
|
4.66% |
|
6.48% |
|
$0.89 |
|
$0.15 |
|
$0.15 |
|